Evidence map›Paper›PMID 42193990›Full record

ReviewBiomolecules2026

C/EBPδ as a Regulatory Node in Adipocytes: Roles in Differentiation, Metabolism, and Immune Function.

Suining Ma, Meiting Lai, Tongjun Li, Lexun Wang, Xianglu Rong

Abstract readReview
In one paragraph

Review in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Suining MaKey Laboratory of Glucolipid Metabolic Diseases, Ministry of Education; Guangdong Provincial TCM Key Laboratory for Metabolic Diseases; Guangdong Provincial Research Center of Integration of Traditional Chinese Medicine and Western Medicine in Metabolic Diseases; Guangdong Pharmaceutical University, Guangzhou 510006, China.
Meiting LaiKey Laboratory of Glucolipid Metabolic Diseases, Ministry of Education; Guangdong Provincial TCM Key Laboratory for Metabolic Diseases; Guangdong Provincial Research Center of Integration of Traditional Chinese Medicine and Western Medicine in Metabolic Diseases; Guangdong Pharmaceutical University, Guangzhou 510006, China.
Tongjun LiKey Laboratory of Glucolipid Metabolic Diseases, Ministry of Education; Guangdong Provincial TCM Key Laboratory for Metabolic Diseases; Guangdong Provincial Research Center of Integration of Traditional Chinese Medicine and Western Medicine in Metabolic Diseases; Guangdong Pharmaceutical University, Guangzhou 510006, China.
Lexun WangKey Laboratory of Glucolipid Metabolic Diseases, Ministry of Education; Guangdong Provincial TCM Key Laboratory for Metabolic Diseases; Guangdong Provincial Research Center of Integration of Traditional Chinese Medicine and Western Medicine in Metabolic Diseases; Guangdong Pharmaceutical University, Guangzhou 510006, China.ORCID 0000-0002-7476-6645
Xianglu RongKey Laboratory of Glucolipid Metabolic Diseases, Ministry of Education; Guangdong Provincial TCM Key Laboratory for Metabolic Diseases; Guangdong Provincial Research Center of Integration of Traditional Chinese Medicine and Western Medicine in Metabolic Diseases; Guangdong Pharmaceutical University, Guangzhou 510006, China.

Funding

National Natural Science Foundation of China 82474228
6 · The paper itself

Abstract

CCAAT/enhancer-binding protein δ (C/EBPδ) is a rapidly responsive transcription factor that occupies an important regulatory position in adipocytes. Induced during the early stage of adipocyte differentiation, C/EBPδ integrates hormonal, inflammatory, metabolic, and stress-related cues and contributes to the coordination of downstream transcriptional and functional programs. Beyond its role in the initiation of differentiation, C/EBPδ is also involved in adipogenic progression, metabolic regulation, and immune-related functions in adipocytes. Current evidence indicates that C/EBPδ participates in early adipogenic regulatory networks, contributes to lipid metabolic programs, and is associated with immune-regulatory processes linked to lipid antigen presentation. Notably, the biological output of C/EBPδ is strongly shaped by tissue type, developmental stage, and microenvironmental context, ranging from promotion of adipogenic differentiation to regulation of inflammatory, metabolic, and adaptive stress responses under distinct physiological and pathological conditions. This review summarizes the upstream regulatory network, downstream functional framework, and context-dependent roles of C/EBPδ in adipocytes, and further discusses its potential relevance to adipose-related diseases as well as the opportunities and challenges for future precision intervention strategies.

Indexed as

AdipocytesCCAAT-Enhancer-Binding Protein-deltaAdipogenesisAnimalsCell DifferentiationHumansLipid MetabolismCCAAT-Enhancer-Binding Protein-deltaadipocyte differentiationadipogenesisC/EBPδcontext dependenceimmune regulation

Identifiers

PMID42193990
PMCPMC13205052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.